Special: Warren Buffett Was WRONG on This One… Time for YOU to Profit!



SBBP: Strongbridge Biopharma is a Buy

The current rating for SBBP is 100, which is 100% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.